Alnylam Pharmaceuticals (ALNY)
(Delayed Data from NSDQ)
$143.31 USD
-0.40 (-0.28%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $143.37 +0.06 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: BMO |
3/2024 | $-0.75 | 5.87% |
Earnings Summary
For their last quarter, Alnylam Pharmaceuticals (ALNY) reported earnings of -$1.10 per share, beating the Zacks Consensus Estimate of $-1.20 per share. This reflects a positive earnings surprise of 8.33%. Look out for ALNY's next earnings release on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.75 per share, reflecting a year-over-year increase of 46.43%.
Earnings History
Price & Consensus
Zacks News for ALNY
Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?
ALNY: What are Zacks experts saying now?
Zacks Private Portfolio Services